Intuitive Surgical, Inc. (NASDAQ:ISRG) is Orbimed Advisors LLC's 4th Largest Position

Orbimed Advisors LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 401,700 shares of the medical equipment provider's stock after selling 32,100 shares during the quarter. Intuitive Surgical makes up 4.6% of Orbimed Advisors LLC's portfolio, making the stock its 4th biggest holding. Orbimed Advisors LLC owned approximately 0.11% of Intuitive Surgical worth $209,671,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Truist Financial decreased their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 2,401 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 188 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total transaction of $106,584.72. Following the sale, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,636 shares of company stock valued at $16,829,815 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $561.43 on Tuesday. The company has a market capitalization of $201.23 billion, a PE ratio of 87.59, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52 week low of $379.67 and a 52 week high of $616.00. The company's 50-day simple moving average is $500.80 and its 200 day simple moving average is $535.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.